Comments
Loading...
Chimerix (CMRX) Forecast
NewsEarningsChimerix (CMRX) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestChimerix (NASDAQ:CMRX) Stock Quotes, Forecast and News Summary
Chimerix Stock (NASDAQ: CMRX) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Chimerix (CMRX) stock?
You can purchase shares of Chimerix (NASDAQ:CMRX) through any online brokerage.
Who are Chimerix (CMRX) competitors?
Other companies in Chimerix’s space includes: KalVista Pharma (NASDAQ:KALV), Humacyte (NASDAQ:HUMA), Upstream Bio (NASDAQ:UPB), Celcuity (NASDAQ:CELC) and Altimmune (NASDAQ:ALT).
What is the forecast, or price target, for Chimerix (CMRX) stock?
Chimerix has a consensus price target of $7.75.
What is the current price for Chimerix (CMRX)?
The stock price for Chimerix (NASDAQ: CMRX) is $5.19 last updated February 21, 2025 at 10:41 AM EST.
Does Chimerix (CMRX) pay a dividend?
There are no upcoming dividends for Chimerix.
When is Chimerix (NASDAQ:CMRX) reporting earnings?
Chimerix’s Q1 earnings are confirmed for Wednesday, April 30, 2025.
Is Chimerix (CMRX) going to split?
There is no upcoming split for Chimerix.
What sector and industry does Chimerix (CMRX) operate in?
Chimerix is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.